OliX PharmaceuticalsInc Cash Flow Reinvestment Rate

Latest as of September 2025: 33.72x

OliX PharmaceuticalsInc cash flow reinvestment rate. OliX PharmaceuticalsInc (226950) has a Cash Flow Reinvestment Rate of 33.72x as of September 2025, reinvesting ₩108.78 Billion (capex ₩623.14 Million plus investments ₩-108.16 Billion) from operating cash flow of ₩3.23 Billion. Explore OliX PharmaceuticalsInc cash debt coverage ratio to assess how comfortably operating cash covers total debt obligations.

Reinvestment Rate

33.72x
(Capex + Investments) / Operating CF

Total Reinvested

₩108.78 Billion
Capex + Investments

Operating Cash Flow

₩3.23 Billion
KRW

Capital Expenditures

₩623.14 Million
KRW

OliX PharmaceuticalsInc Cash Flow Reinvestment Rate by Year (None–None)

OliX PharmaceuticalsInc cash flow reinvestment rate by year from None to None. Year-by-year capital reinvestment analysis for OliX PharmaceuticalsInc. For the full cash flow conversion analysis, see cash efficiency ratio of OliX PharmaceuticalsInc.

Year Reinvestment Rate Total Reinvested (KRW) Operating CF Capex YoY Change
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow